Anxo Pharmaceutical Statistics

Total Valuation

TPEX:6677 has a market cap or net worth of TWD 1.01 billion. The enterprise value is 1.49 billion.

Market Cap	1.01B
Enterprise Value	1.49B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6677 has 55.81 million shares outstanding. The number of shares has increased by 12.23% in one year.

Current Share Class	n/a
Shares Outstanding	55.81M
Shares Change (YoY)	+12.23%
Shares Change (QoQ)	+2.95%
Owned by Insiders (%)	1.88%
Owned by Institutions (%)	0.90%
Float	29.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.13
PB Ratio	0.88
P/TBV Ratio	1.03
P/FCF Ratio	14.47
P/OCF Ratio	9.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 78.19, with an EV/FCF ratio of 21.40.

EV / Earnings	-26.04
EV / Sales	1.66
EV / EBITDA	78.19
EV / EBIT	n/a
EV / FCF	21.40

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.64.

Current Ratio	1.75
Quick Ratio	1.15
Debt / Equity	0.64
Debt / EBITDA	38.13
Debt / FCF	10.44
Interest Coverage	-3.39

Financial Efficiency

Return on equity (ROE) is -4.62% and return on invested capital (ROIC) is -1.83%.

Return on Equity (ROE)	-4.62%
Return on Assets (ROA)	-1.63%
Return on Invested Capital (ROIC)	-1.83%
Return on Capital Employed (ROCE)	-3.52%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.41
Inventory Turnover	2.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.88% in the last 52 weeks. The beta is 0.10, so TPEX:6677's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	-58.88%
50-Day Moving Average	22.59
200-Day Moving Average	29.45
Relative Strength Index (RSI)	35.21
Average Volume (20 Days)	70,162

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6677 had revenue of TWD 895.32 million and -57.21 million in losses. Loss per share was -1.03.

Revenue	895.32M
Gross Profit	325.48M
Operating Income	-56.57M
Pretax Income	-60.02M
Net Income	-57.21M
EBITDA	4.10M
EBIT	-56.57M
Loss Per Share	-1.03

Full Income Statement

Balance Sheet

The company has 361.14 million in cash and 726.63 million in debt, giving a net cash position of -365.49 million or -6.55 per share.

Cash & Cash Equivalents	361.14M
Total Debt	726.63M
Net Cash	-365.49M
Net Cash Per Share	-6.55
Equity (Book Value)	1.14B
Book Value Per Share	18.32
Working Capital	375.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 111.97 million and capital expenditures -42.34 million, giving a free cash flow of 69.63 million.

Operating Cash Flow	111.97M
Capital Expenditures	-42.34M
Free Cash Flow	69.63M
FCF Per Share	1.25

Full Cash Flow Statement

Margins

Gross margin is 36.35%, with operating and profit margins of -6.32% and -6.39%.

Gross Margin	36.35%
Operating Margin	-6.32%
Pretax Margin	-6.70%
Profit Margin	-6.39%
EBITDA Margin	0.46%
EBIT Margin	-6.32%
FCF Margin	7.78%

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 2.23%.

Dividend Per Share	0.40
Dividend Yield	2.23%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-12.23%
Shareholder Yield	-10.00%
Earnings Yield	-5.68%
FCF Yield	6.91%

Dividend Details

Stock Splits

The last stock split was on November 1, 2021. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 1, 2021
Split Type	Forward
Split Ratio	1.05

Scores

TPEX:6677 has an Altman Z-Score of 1.88. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.88
Piotroski F-Score	n/a